Proscar Does Not Need to Be Stopped Before Surgery
Proscar (finasteride) does not require discontinuation before surgery. There is no evidence-based recommendation or pharmacological rationale for stopping finasteride prior to surgical procedures.
Key Points
No Perioperative Management Required
- Finasteride is not an antithrombotic or antiplatelet agent and does not increase bleeding risk during surgery. 1
- The drug's mechanism involves competitive inhibition of Type II 5α-reductase, which converts testosterone to dihydrotestosterone (DHT) in the prostate, liver, and skin—this has no impact on coagulation or hemostasis. 1
- The FDA-approved prescribing information for Proscar contains no warnings or precautions regarding perioperative discontinuation. 1
Pharmacokinetic Considerations
- Finasteride has a plasma elimination half-life of approximately 6 hours (range 3-16 hours), with mean plasma clearance of 165 mL/min. 1
- The drug undergoes extensive hepatic metabolism via cytochrome P450 3A4, with approximately 39% excreted in urine as metabolites and 57% in feces. 1
- These pharmacokinetic properties do not necessitate preoperative discontinuation, as the drug does not interfere with surgical hemostasis or wound healing. 1
Clinical Context
- The provided guidelines address perioperative management of antithrombotic therapy (aspirin, clopidogrel, ticagrelor, prasugrel) which require specific timing for discontinuation due to bleeding risk. 2, 3
- Finasteride falls into an entirely different drug class (5α-reductase inhibitor) and is not subject to these perioperative management protocols. 1
Common Pitfall to Avoid
Do not confuse finasteride with antiplatelet or anticoagulant medications that require preoperative discontinuation. Finasteride can be continued through the perioperative period without adjustment to the dosing schedule. 1